The Effect of Body Image Concerns, Anxiety, and Depression on Sexual Problems in Gynecological Cancer Patients

The Effect of Body Image Concerns, Anxiety, and Depression on Sexual Problems in Gynecological Cancer Patients

SUMMARY Gynecological cancers and their treatments directly affect the female genitals. Therefore, gynecologi- cal cancers are one of the cancer types where sexual dysfunctions are most common. Sexual problems can be a normal result of treatment processes and of cancer, as well as a reflection of the psychological difficulties experienced by individuals during the disease process. The disease itself and the treatments applied can cause psychiatric problems such as body image concern, depression, anxiety, decreased self- esteem, sleep disorders, and sexual dysfunction affect the quality of life negatively. The psychological treatment methods include psychoeducation, group therapy, sexual counseling, marriage counseling, structured psychotherapy, and brief psychosexual interventions. Psychiatric symptoms should be con- sidered to emerge following treatment and quality of life and sexual functions may be adversely affected in gynecological cancer patients, and a multidisciplinary approach including psychological treatment and symptom management should be provided for the effective treatment of sexual difficulties.

___

  • 1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer sta- tistics, 2022. CA Cancer J Clin 2022;72(1):7–33.
  • 2. International Agency for Research on Cancer (IARC) GLOBOCAN 2020. Available at: https://gco.iarc.fr/to- day/online-analysis-table. Accessed Nov 3, 2021.
  • 3. Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexu- ality and intimacy after gynecological cancer. Maturi- tas 2010;66(1):23–6.
  • 4. WHO. Education and treatment in human sexual- ity: the training of health professionals, report of a WHO meeting [held in Geneva from 6 to 12 Febru- ary 1974]. Available at: http://apps.who.int/iris/han- dle/10665/38247. Accessed Nov 3 ,2021.
  • 5. Jonczak EE, Stone ER, Pravia CI, Sider D. Life after breast, prostate, and colon cancer: Primary care’s role. Cleve Clin J Med 2017;84(4):303–9.
  • 6. Çavdar İ. Meme kanserli hastalarda cinsel sorunlar. Meme Sağlığı Dergisi 2006;2(2):64–6.
  • 7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281(6):537–44.
  • 8. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998;15(6):519–24.
  • 9. Onujiogu N, Johnson T, Seo S, Mijal K, Rash J, Se- aborne L, et al. Survivors of endometrial cancer: who is at risk for sexual dysfunction? Gynecol Oncol 2011;123(2):356–9.
  • 10. Shankar A, Prasad N, Roy Sh, Chakraborty A, Biswas ASh, Patil Jet al. Sexual dysfunction in females after cancer treatment: an unresolved issue. Asian Pac J Cancer Prev 2017;18(5):1177–82.
  • 11. Tsai TY, Chen SY, Tsai MH, Su YL, Ho CM, Su HF. Prevalence and associated factors of sexual dysfunction in cervical cancer patients. J Sex Med 2011;8(6):1789– 96.
  • 12. Tee BC, Rasidi AMS, Rushdan MMN, Ismail A, Sidi H. The prevalence and risk factors of sexual dysfunc- tion in gynaecological cancer patients. Med & Health 2014;9(1):53–61.
  • 13. Krebs LU. Sexual and reproductive dysfunction. In: Yarbro CH, Wujcik D, Gobel BH, editors. Cancer Nursing. 8th ed. Massachusetts: Jones & Bartlett Learn- ing; 2018. p. 1011–50.
  • 14. Demirtas B, Pinar G. Determination of sexual prob- lems of Turkish patients receiving gynecologic cancer treatment: a cross-sectional study. Asian Pac J Cancer Prev 2014;15(16):6657–63
  • 15. Carter J, Stabile C, Gunn A, Sonoda Y. The physical consequences of gynecologic cancer surgery and their impact on sexual, emotional, and quality of life issues. J Sex Med 2013;10 Suppl 1:21–34.
  • 16. Huffman LB, Hartenbach EM, Carter J, Rash JK, Kush- ner DM. Maintaining sexual health throughout gyne- cologic cancer survivorship: A comprehensive review and clinical guide. Gynecol Oncol 2016;140(2):359– 68.
  • 17. Iżycki D, Woźniak K, Iżycka N. Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective. Prz Menopauzalny 2016;15(2):112–6.
  • 18. Vitale SG, La Rosa VL, Rapisarda AMC. Comment on: “The consequences of gynaecological cancer in patients and their partners from the sexual and psychological perspective”. Prz Menopauzalny 2016;15:186–7.
  • 19. Cakar B, Karaca B, Uslu R. Sexual dysfunction in can- cer patients: a review. JBUON 2013;18(4):818–23.
  • 20. Bober SL, Varela VS. Sexuality in adult cancer sur- vivors: challenges and intervention. J Clin Oncol 2012;30(30):3712–9.
  • 21. Bodurka DC, Sun CC. Sexual function after gy- necologic cancer. Obstet Gynecol Clin North Am 2006;33(4):621–30, ix.
  • 22. Levin AO, Carpenter KM, Fowler JM, Brothers BM, Andersen BL, Maxwell GL. Sexual morbidity asso- ciated with poorer psychological adjustment among gynecological cancer survivors. Int J Gynecol Cancer 2010;20(3):461–70.
  • 23. Roland KB, Rodriguez JL, Patterson JR, Trivers KF. A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology 2013;22(11):2408–18.
  • 24. Bukovic D, Rudan I, Gorski D, Bukovic D. Psycho- sexual dysfunction following gynecological tumor surgery. Collegium Antropologicum 1996;20(1):129– 38.
  • 25. Burns M, Costello J, Ryan-Woolley B, Davidson S. Assessing the impact of late treatment effects in cervi- cal cancer: an exploratory study of women’s sexuality. Eur J Cancer Care (Engl) 2007;16(4):364–72.
  • 26. Sertöz ÖÖ, Elbi Mete H, Noyan A, Alper M, Kapkaç M. Meme kanserinde ameliyat tipinin beden algısı, cinsel işlevler, benlik saygısı ve eş uyumuna etki- leri: kontrollü bir çalışma. Türk Psikiyatri Dergisi 2004;15(4):264–75.
  • 27. Farooqi YN. Depression and anxiety in patients un- dergoing hysterectomy. J Pakistan Psychiatric Soc 2005;2(1):13–16.
  • 28. Donovan KA, Taliaferro LA, Alvarez EM, Jacobsen PB, Roetzheim RG, Wenham RM. Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol 2007;104(2):428–34.
  • 29. Stead ML, Fallowfield L, Selby P, Brown JM. Psycho- sexual function and impact of gynaecological cancer. Best Pract Res Clin Obstet Gynaecol 2007;21(2):309– 20.
  • 30. Kornblith AB, Ligibel J. Psychosocial and sexual func- tioning of survivors of breast cancer. Semin Oncol 2003;30(6):799–813.
  • 31. Marrs JA. Stress, fears, and phobias: the impact of anx- iety. Clin J Oncol Nurs 2006;10(3):319–22.
  • 32. Larrison EH. Sexuality issues. In: Lockwood S, edi- tor. Women’s Cancer. 1st ed. Sudbury, USA: Jones and Bartlett; 2009. p.209.
  • 33. Bukovic D, Silovski H, Silovski T, Hojsak I, Sakic K, Hrgovic Z. Sexual functioning and body image of patients treated for ovarian cancer. Sex Disabil 2008;26(2):63–73.
  • 34. Steele R, Fitch MI. Supportive care needs of women with gynecologic cancer. Cancer Nurs 2008;31(4):284– 91.
  • 35.Meston CM, Hull E, Levin RJ, Sipski M. Kadın orgazmı. In: Lue TF, Basson R, Rosen R, Giuiano F, Khoury S, Montorsi F, editors. Seksüel Tıp. 1st ed. Is- tanbul: İstanbul Medikal Yayıncılık; 2006. p.785–812.
  • 36. Basson R. Kadın cinselliği ve cinsel bozukluklar. In: Gibbs R, Karlan B, Haney A, Nygaard I, editors. Dan- forth’s Obstetrik ve Jinekoloji. 10th ed. Ankara: Güneş Tıp Kitabevleri; 2010. p. 742–48.
  • 37. Laurent SM, Simons AD. Sexual dysfunction in de- pression and anxiety: conceptualizing sexual dysfunc- tion as part of an internalizing dimension. Clin Psy- chol Rev 2009;29(7):573–85.
  • 38. Valentine A. Depression, anxiety, & delirium. In: Paz- dur R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer management: A multidisciplinary approach. New York: The Oncology Group; 2003. p. 865–79.
  • 39. Holt KA, Mogensen O, Jensen PT, Hansen DG. Goal setting in cancer rehabilitation and relation to quality of life among women with gynaecological cancer. Acta Oncol 2015;54(10):1814–23.
  • 40. Yıldırım NK, Özkan M, Özkan S, Özçınar B, Güler SA, Özmen V. Meme kanserli hastaların tedavi öncesi ve sonrası anksiyete, depresyon, yaşam kalitesi. Nörop- sikiyatri Arşivi 2009;46(1):175–81.
  • 41. Durmuşoğlu F, Erenus M. Nörovejetatif Semptomlar. In: Ertüngealp E, Seyisoğlu H, editors. Menopoz ve osteoporoz. 1st ed. Istanbul: Form Reklam Hizmetleri; 2000. p. 23–6.
  • 42. Erel T. Menopozda genitoüriner trofik bozukluklar. In: Ertüngealp E, Seyisoğlu H, editors. Menopoz ve Osteoporoz. 1st ed. Istanbul: Form Reklam Hizmetleri; 2000. p.42, 63–6.
  • 43. Öztürk MO, Uluşahin A. Ruh sağlığı bozuklukları. 11th ed. Ankara: Tuna Matbaacılık; 2008. p. 37–9, 269, 853.
  • 44. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical can- cer. Int J Radiat Oncol Biol Phys 2003;56(4):937–49.
  • 45. Pomel C, Atallah D, Le Bouedec G, Rouzier R, Morice P, Castaigne D, et al. Laparoscopic radical hysterec- tomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol 2003;91(3):534–9.
  • 46. Wenzel LB, Donnelly JP, Fowler JM, Habbal R, Tay- lor TH, Aziz N, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gy- necologic oncology group study. Psychooncology 2002;11(2):142–53.
Türk Onkoloji Dergisi-Cover
  • ISSN: 1300-7467
  • Başlangıç: 2015
  • Yayıncı: Ali Cangül
Sayıdaki Diğer Makaleler

Can A Dedicated Multidisciplinary Tumor Board Improve Personalized Medicine for Patients in Interventional Oncology? A Large Retrospective Single-Center Experience

Roberto IEZZI, Bruno FIONDA, Patrizia CORNACCHİONE, Martina IEZZI, Valentina LANCELLOTTA, Andrea CONTEGIACOM, Fabia ATTILI, Alberto LARGHI, Francesco CELLINI, Fabio MARAZZI, Giuseppe COLLOCA, Ángeles ROVIROSA, György KOVÁCS, Maria Antonietta GAMBACORTA, Riccardo MANFREDI, Vincenzo VALENTIN, Luca TAG

Nanocrystal’s Formulation of Biological Response Modifier P-MAPA on Bladder Cancer Compared to Bacillus Calmette-Guerin Immunomodulator

Wagner José FÁVARO, Ana Claudia SILVA LIMA, Queila Cristina DIAS, Patrick Vianna GARCIA, Nelson DURÁN

Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma

Gonca HANEDAN USLU, Çağlar YILDIZ AKDENİZ, Nihat YEŞILIRMAK

Survivin As an Immunohistochemical Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis

Sedef Hande AKTAŞ, Büşra EMİR, Dilara Fatma AKIN BALI, Ozan YAZICI

Comparative Study of Marketed and Novel Colloidal Formulation for Topical Delivery of 5-Fluorouracil to Skin Cancer Cells: Ex-Vivo Release Study and Cytotoxicity Analysis

Harish SHARMA, Gyanesh Kumar SAHU, Swarnali Das PAUL, Chanchal Deep KAUR

Pattern of Recurrence and Survival Outcomes in Non-Metastatic Triple-Negative Breast Cancer; A Retrospective Analysis

Jayaraman KANNAN, Srigopal MOHANTY, Amit SAKLANI, Deepak GEORGE, Natarajan INGERSAL

The Impact of Sex Hormone-Binding Globulin Levels on Thromboembolic Events at Patients with Advanced Stage Adenocarcinoma

Mustafa BOZKURT

Dosimetric and Radiobiological Evaluation of Radiation-induced Pulmonary Toxicity in the Esophageal Malignancy Using VMAT

Sanjib GAYEN, Shekhar ANAND, Sumanta MANNA, Sri Harsha KOMBATHULA, Sweta SONI, Akanksha SOLANKI, Sonal VARSHNEY, Puneet PAREEK

Oxidative Stress Has a Negative Effect on the Development and Progression of Bladder Cancer

Murat DEMİR, Canan DEMİR

Radiotherapy in Cancer Treatment During The Covid-19 Pandemic: One Year Results From Northeast Turkey

Özlem AYNACI, Lasif SERDAR, Sema RAKICI, Seher KAZAZ, Emine CANYILMAZ, Zümrüt BAHAT, Ahmet Yaşar ZENGİN